By proceeding, you agree to our Terms of Use and Privacy Policy.
The 3rd TLR & PRR-Targeted Therapies Summit is coming at a timely inflection point in this field.
Speakers will shed light on optimizing various drug format options and the next steps in PRR combination interventions to heighten drug effect.
With the convergence of experts, you will learn the development of predictive preclinical models in PRR research to achieve human-specific translation.
Networking with clinical experts will propel your business through the barriers it faces to achieve clinical breakthrough in targeted therapies.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.